Furthermore, the authors linked ROR1 with EMT, and showed that their anti-ROR1 monoclonal antibody inhibited ovarian cancer xenograft growth and reduced expression of EMT markers [19]. The gene discussed is ROR1; the disease is ovarian carcinoma.